'Misuse' of Ozempic causing shortage in Malaysia

Demand soars amid global craze over use of diabetes medication for weight loss

- 

PETALING JAYA - The global craze over Ozempic as a weight-loss solution has hit Malaysia, with pharmacies experiencing a surge in demand for the diabetes medication, resulting in a shortage.

Malaysian Pharmacists Society president Amrahi Buang confirmed the shortage, attributing it to increased demand from non-diabetic individuals taking it for its weight loss effects.

"There are many who are interested only in the drug's weight loss potency, creating a huge demand and a shortage in the market," he said.

Mr Amrahi noted that Ozempic, while requiring a prescription, is somehow being accessed by non-diabetics.

"This is supported by many reports of Ozempic being misused by non-diabetic individuals for weight loss, although it is not approved for that purpose in Malaysia."

Mr Amrahi warned against using drugs for unapproved purposes without medical supervision, emphasising that potential side effects of Ozempic include hypoglycaemia or low blood sugar, which could be life-threatening.

"The public should always consult pharmacists on the proper use of medication to prevent unintended consequences," he said.

Ozempic is a semaglutide, which is an injectable medication that helps adults with Type 2 diabetes manage their blood sugar levels.